Humanetics Corporation, a leading researcher, developer and marketer of pharmaceuticals, medical foods and branded nutraceutical ingredients, announced recently that it has sold its 7-Keto dietary ingredient brand to InterHealth Nutraceuticals, Inc. of Benica, CA (InterHealth). 7-Keto is a clinically tested, patented ingredient that slows the impact of diet and age-related weight gain.
“Humanetics developed and established the science and value of the 7-Keto brand over the past twenty years,” said Ronald Zenk, President and CEO of Humanetics Corporation. “We have invested heavily in clinical research and believe that 7-Keto is one of the most scientifically sound products on the market.” He added, “We believe InterHealth will continue to strengthen the 7-Keto brand, and that this transaction will allow Humanetics to focus on its strong portfolio of ongoing pharmaceutical development initiatives.”
According to Paul Dijkstra, President and CEO of InterHealth, “7-Keto fits very nicely into InterHealth’s portfolio of science-based, branded, functional ingredients supported by robust clinical trial and safety data. 7-Keto is sold to many of the industry’s most successful finished product brands and holds a strong position in the marketplace.”
Humanetics will retain the rights to continue development of the 7-Keto technology as a promising treatment for post-traumatic stress disorder. A clinical study at the Bay Pines Veteran’s Administration Hospital in Bay Pines Florida is expected to be completed in late 2014.